Abstract
AXT Inc will report third-quarter 2026 results on October 29, 2026, Post-Mkt, with forecasts indicating a sharp year-over-year rise in revenue and earnings per share and investors focused on execution in core substrate lines and pricing power.Market Forecast
Consensus-style forecasts point to third-quarter revenue of 66.01 million US dollars, adjusted EPS of 0.31, and EBIT of 15.22 million US dollars; the year-over-year growth rates implied by these estimates are 225.08% for revenue, 359.28% for EPS, and 361.04% for EBIT. Margin forecasts are not available in the dataset, and are therefore omitted.Within the company’s revenue mix, the 基板 (Substrates) line carried the bulk of sales last quarter at 37.56 million US dollars, and indications from recent management commentary and market developments suggest continued strength into this quarter. The most promising area remains 基板 (Substrates), which contributed 37.56 million US dollars last quarter, in the context of total company revenue that was up 164.77% year-over-year in that period.
Last Quarter Review
AXT Inc delivered 47.59 million US dollars of revenue last quarter, a gross profit margin of 44.90%, GAAP net profit attributable to the parent of 11.13 million US dollars, a net profit margin of 23.38%, and adjusted EPS of 0.19; these translated to year-over-year growth of 164.77% in revenue and 218.75% in EPS, while quarter-on-quarter net profit growth stood at 78,691% on the tool’s decimal-ratio basis. A key highlight was the record contribution from indium phosphide-related activity, with commentary describing the quarter as an inflection rather than a one-off uptick. In terms of business composition, 基板 (Substrates) accounted for 37.56 million US dollars and 原材料及其他 (Raw materials and others) for 10.03 million US dollars, set against total revenue growth of 164.77% year-over-year.Current Quarter Outlook
Main Business: 基板 (Substrates)
The core substrate portfolio is central to this quarter’s outcome because it dominates the company’s revenue mix and carries the operating leverage that amplifies margin changes. Last quarter’s 37.56 million US dollars from 基板 (Substrates) underscores the scale of this line and its sensitivity to pricing, throughput, and mix. With the current-quarter revenue estimate at 66.01 million US dollars and EBIT at 15.22 million US dollars, execution in substrate production—yield management, wafer size utilization, and cycle times—will be the primary determinant of how close AXT Inc tracks to or surpasses these forecasts. Pricing discipline, supported by tight availability and prioritization of higher-value orders, can help sustain the gross profit margin profile; any improvement in cost absorption as volumes ramp typically supports operating margin expansion. Operationally, stable materials input, controlled scrap rates, and consistency in delivery schedules have a direct bearing on reported margins this quarter, so investors will watch the cadence of shipments and customer acceptance closely.Most Promising Segment: 基板 (Substrates) with Indium Phosphide Activity
The most compelling growth potential continues to be embedded in the substrate segment, where last quarter’s contribution of 37.56 million US dollars aligned with evidence of accelerating demand and favorable mix. The news flow around record quarterly performance and commentary highlighting an inflection point supports the view that this area can compound gains through both volume and price. The current-quarter forecast of adjusted EPS at 0.31 (implying 359.28% year-over-year growth) is consistent with margin accretion when high-value substrate shipments dominate; EBIT’s implied 361.04% year-over-year growth reinforces this linkage. Investors should monitor whether backlog conversion rates and shipment linearity remain robust, because a smooth run-rate through the quarter helps defend gross margin from production variances. Additionally, any signals of stronger-than-expected customer ramp or broader mix improvement across substrate sizes would be positive for both revenue and earnings trajectory.Stock Price Drivers This Quarter
Near-term stock performance is likely to hinge on three operational variables: delivery momentum relative to the 66.01 million US dollars revenue estimate, realized gross margins versus last quarter’s 44.90%, and the degree to which earnings quality tracks the forecasted 0.31 adjusted EPS. An earnings print that validates EBIT near 15.22 million US dollars while preserving margin durability would be consistent with the “inflection” narrative embedded in prior commentary, typically supporting constructive sentiment. Conversely, any evidence of shipment timing slippage or cost volatility that pressures EBIT away from the 15.22 million US dollars trajectory could temper enthusiasm and introduce volatility around the print. The constellation of analyst views skews supportive, which heightens sensitivity to whether reported numbers corroborate the implied growth rates of 225.08% for revenue and 359.28% for EPS; beats on either metric, especially with reaffirmed operational execution, would likely reinforce positive momentum.Analyst Opinions
Bullish perspectives dominate recent commentary and rating actions in our collection window, with a bullish-to-bearish ratio of 3:0. Wedbush characterized last quarter’s results as having “handily” exceeded prior outlook and consensus on strong demand for indium phosphide substrates, noting that management viewed the quarter as “an inflection point in the business rather than a one-quarter step-up,” and concluding, “we see no reason to bet against AXTI,” while maintaining an outperform rating and a 93 US dollars price target (July 31, 2026). Additional rating updates in the six-month window reiterate constructive stances, including continued Buy/Outperform positioning from Wedbush. Meanwhile, B. Riley’s neutral stance with a 55 US dollars price target (July 31, 2026) offers a balancing view but does not materially shift the preponderance of bullish commentary.From an analytical standpoint, the bullish case emphasizes a high-velocity revenue and earnings trajectory into the current quarter: the 66.01 million US dollars revenue estimate implies 225.08% year-over-year growth, with EBIT at 15.22 million US dollars suggesting 361.04% year-over-year growth and adjusted EPS at 0.31 implying 359.28% year-over-year growth. The prior quarter’s 47.59 million US dollars revenue, 44.90% gross margin, and 0.19 adjusted EPS—each with triple-digit year-over-year growth—provide tangible validation of operating momentum. Analysts in the majority camp frame this quarter’s report as a test of continuity: if the company sustains substrate throughput, preserves pricing power, and converts backlog efficiently, the earnings path projected by the current-quarter forecast is attainable. In qualitative terms, the bullish view is underpinned by execution evidence and reinforced by commentary that positions the most recent quarterly performance as the start of a multi-quarter trend rather than a transient spike. On that basis, the majority expects a constructive print, with attention on gross margin resilience and EBIT quality as confirming markers.
Comments